Trials / Completed
CompletedNCT02139241
The Efficacy and Safety of Ramosetron in Patients Undergoing Off Pump Coronary Artery Bypass Surgery
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 114 (actual)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the effects of ramosetron on corrected QT interval in patients undergoing off pump coronary artery bypass surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ramosetron | 0.3 mg IV as bolus before induction of general anesthesia |
| DRUG | Normal saline | 2 ml normal saline as bolus before induction of general anesthesia |
Timeline
- Start date
- 2013-06-01
- Primary completion
- 2014-10-01
- Completion
- 2014-10-01
- First posted
- 2014-05-15
- Last updated
- 2015-11-20
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02139241. Inclusion in this directory is not an endorsement.